Rodney W Benner1, K Donald Shelbourne1, Tinker Gray2. 1. Shelbourne Knee Center, Indianapolis, Indiana, USA. 2. Shelbourne Knee Center, Indianapolis, Indiana, USA tgray@fixknee.com.
Abstract
BACKGROUND: There is concern that high degrees of hyperextension may lead to an increase in graft laxity or graft failure after anterior cruciate ligament (ACL) reconstruction. HYPOTHESIS: Patients with a high degree of hyperextension will have a higher rate of graft tear/failure and lower subjective scores after surgery compared with patients with less knee extension. STUDY DESIGN: Cohort study, Level of evidence, 2. METHODS: Of 2329 patients who underwent ACL reconstruction with patellar tendon autograft between 1998 and 2008, there were 625 patients who met the inclusion criteria of having primary ACL surgery, no bilateral ACL injuries, no existing osteoarthritis, and having either ≥6° of knee hyperextension before and after surgery (group A: n = 318; mean hyperextension, 8° ± 2° [range, 6°-15°]) or ≤3° of knee hyperextension before and after surgery (group B: n = 307; mean hyperextension, 0° ± 3° [range, 3° hyperextension to -4° short of 0° neutral]). KT-1000 arthrometer manual maximum difference between knees, range of motion measurements, and subjective follow-up with International Knee Documentation Committee (IKDC) and Cincinnati Knee Ratings Scale (CKRS) surveys were used to evaluate results. Subsequent graft tear related to specific injury within 5 years of surgery was recorded. Graft failure was defined as a KT-1000 manual maximum difference of >5 mm. RESULTS: Follow-up was obtained from 278 (87%) in group A and 275 (90%) in group B at a mean of 4.1 ± 1.1 years after surgery. The KT-1000 arthrometer manual maximum difference between knees was 2.0 ± 1.4 in group A and 2.1 ± 1.6 in group B (P = .701). Subsequent ACL graft tear/failure occurred in 22 patients (6.9%) in group A and 30 patients (9.8%) in group B (P = .246). Further subanalysis showed that the graft tear/failure rate was 6 of 81 (7.4%) for patients with ≥10° of hyperextension versus 16 of 237 (6.8%) for patients with 6° to 9° of hyperextension. There was no difference in IKDC or CKRS scores between groups after surgery (P = .933 and .155, respectively). CONCLUSION: Obtaining full hyperextension that is anatomically normal for most patients does not affect objective stability, ACL graft tear/failure rates, or subjective scores after ACL reconstruction with patellar tendon autograft.
BACKGROUND: There is concern that high degrees of hyperextension may lead to an increase in graft laxity or graft failure after anterior cruciate ligament (ACL) reconstruction. HYPOTHESIS: Patients with a high degree of hyperextension will have a higher rate of graft tear/failure and lower subjective scores after surgery compared with patients with less knee extension. STUDY DESIGN: Cohort study, Level of evidence, 2. METHODS: Of 2329 patients who underwent ACL reconstruction with patellar tendon autograft between 1998 and 2008, there were 625 patients who met the inclusion criteria of having primary ACL surgery, no bilateral ACL injuries, no existing osteoarthritis, and having either ≥6° of knee hyperextension before and after surgery (group A: n = 318; mean hyperextension, 8° ± 2° [range, 6°-15°]) or ≤3° of knee hyperextension before and after surgery (group B: n = 307; mean hyperextension, 0° ± 3° [range, 3° hyperextension to -4° short of 0° neutral]). KT-1000 arthrometer manual maximum difference between knees, range of motion measurements, and subjective follow-up with International Knee Documentation Committee (IKDC) and Cincinnati Knee Ratings Scale (CKRS) surveys were used to evaluate results. Subsequent graft tear related to specific injury within 5 years of surgery was recorded. Graft failure was defined as a KT-1000 manual maximum difference of >5 mm. RESULTS: Follow-up was obtained from 278 (87%) in group A and 275 (90%) in group B at a mean of 4.1 ± 1.1 years after surgery. The KT-1000 arthrometer manual maximum difference between knees was 2.0 ± 1.4 in group A and 2.1 ± 1.6 in group B (P = .701). Subsequent ACL graft tear/failure occurred in 22 patients (6.9%) in group A and 30 patients (9.8%) in group B (P = .246). Further subanalysis showed that the graft tear/failure rate was 6 of 81 (7.4%) for patients with ≥10° of hyperextension versus 16 of 237 (6.8%) for patients with 6° to 9° of hyperextension. There was no difference in IKDC or CKRS scores between groups after surgery (P = .933 and .155, respectively). CONCLUSION: Obtaining full hyperextension that is anatomically normal for most patients does not affect objective stability, ACL graft tear/failure rates, or subjective scores after ACL reconstruction with patellar tendon autograft.
Authors: Kanto Nagai; Tom Gale; Elmar Herbst; Yasutaka Tashiro; James J Irrgang; Scott Tashman; Freddie H Fu; William Anderst Journal: Knee Surg Sports Traumatol Arthrosc Date: 2017-07-15 Impact factor: 4.342
Authors: Daniel E Cooper; Warren R Dunn; Laura J Huston; Amanda K Haas; Kurt P Spindler; Christina R Allen; Allen F Anderson; Thomas M DeBerardino; Brett Brick A Lantz; Barton Mann; Michael J Stuart; John P Albright; Annunziato Ned Amendola; Jack T Andrish; Christopher C Annunziata; Robert A Arciero; Bernard R Bach; Champ L Baker; Arthur R Bartolozzi; Keith M Baumgarten; Jeffery R Bechler; Jeffrey H Berg; Geoffrey A Bernas; Stephen F Brockmeier; Robert H Brophy; Charles A Bush-Joseph; J Brad Butler V; John D Campbell; James L Carey; James E Carpenter; Brian J Cole; Jonathan M Cooper; Charles L Cox; R Alexander Creighton; Diane L Dahm; Tal S David; David C Flanigan; Robert W Frederick; Theodore J Ganley; Elizabeth A Garofoli; Charles J Gatt; Steven R Gecha; James Robert Giffin; Sharon L Hame; Jo A Hannafin; Christopher D Harner; Norman Lindsay Harris; Keith S Hechtman; Elliott B Hershman; Rudolf G Hoellrich; Timothy M Hosea; David C Johnson; Timothy S Johnson; Morgan H Jones; Christopher C Kaeding; Ganesh V Kamath; Thomas E Klootwyk; Bruce A Levy; C Benjamin Ma; G Peter Maiers; Robert G Marx; Matthew J Matava; Gregory M Mathien; David R McAllister; Eric C McCarty; Robert G McCormack; Bruce S Miller; Carl W Nissen; Daniel F O'Neill; Brett D Owens; Richard D Parker; Mark L Purnell; Arun J Ramappa; Michael A Rauh; Arthur C Rettig; Jon K Sekiya; Kevin G Shea; Orrin H Sherman; James R Slauterbeck; Matthew V Smith; Jeffrey T Spang; Steven J Svoboda; Timothy N Taft; Joachim J Tenuta; Edwin M Tingstad; Armando F Vidal; Darius G Viskontas; Richard A White; James S Williams; Michelle L Wolcott; Brian R Wolf; James J York; Rick W Wright Journal: Am J Sports Med Date: 2018-06-08 Impact factor: 6.202
Authors: David Sundemo; Christina Mikkelsen; Riccardo Cristiani; Magnus Forssblad; Eric Hamrin Senorski; Eleonor Svantesson; Kristian Samuelsson; Anders Stålman Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-07-04 Impact factor: 4.342
Authors: Andrew D Firth; Dianne M Bryant; Robert Litchfield; Robert G McCormack; Mark Heard; Peter B MacDonald; Tim Spalding; Peter C M Verdonk; Devin Peterson; Davide Bardana; Alex Rezansoff; Alan M J Getgood; Kevin Willits; Trevor Birmingham; Chris Hewison; Stacey Wanlin; Ryan Pinto; Ashley Martindale; Lindsey O'Neill; Morgan Jennings; Michal Daniluk; Dory Boyer; Mauri Zomar; Karyn Moon; Raely Moon; Brenda Fan; Bindu Mohan; Gregory M Buchko; Laurie A Hiemstra; Sarah Kerslake; Jeremy Tynedal; Greg Stranges; Sheila Mcrae; LeeAnne Gullett; Holly Brown; Alexandra Legary; Alison Longo; Mat Christian; Celeste Ferguson; Nick Mohtadi; Rhamona Barber; Denise Chan; Caitlin Campbell; Alexandra Garven; Karen Pulsifer; Michelle Mayer; Nicole Simunovic; Andrew Duong; David Robinson; David Levy; Matt Skelly; Ajaykumar Shanmugaraj; Fiona Howells; Murray Tough; Pete Thompson; Andrew Metcalfe; Laura Asplin; Alisen Dube; Louise Clarkson; Jaclyn Brown; Alison Bolsover; Carolyn Bradshaw; Larissa Belgrove; Francis Milan; Sylvia Turner; Sarah Verdugo; Janet Lowe; Debra Dunne; Kerri McGowan; Charlie-Marie Suddens; Geert Declerq; Kristien Vuylsteke; Mieke Van Haver Journal: Am J Sports Med Date: 2022-01-20 Impact factor: 6.202